Phase I Study of Rogocekib in Patients with Advanced, Relapsed, or Refractory Malignant Solid Tumors.

rogocekib (CTX-712) - Chordia Therap

http://www.ncbi.nlm.nih.gov/pubmed/42148878

Akio Mizutani; Daisuke Morishita; Eiji Takahara; Hirokazu Tozaki; Hiroshi Miyake; Jun Sato; Kan Yonemori; Maki Yamamoto; Noboru Yamamoto; Robert W Oda; Shingo Shoji; Takafumi Koyama; Toshio Shimizu; Yasushi Tanoue; Yuki Katsuya

May 19, 2026